Company intelligence / Profile preview

Laride

Somerville, Massachusetts, United Statesdnb.com ↗

Ownership: Private
Employees: ~130
Development stage: Other

Overview

Laronde developed a novel endless/circular RNA platform intended for persistent and programmable protein expression. The company faced significant data integrity issues leading to the shelving of its lead programs and ultimately merged with Senda Biosciences in 2023. No clinical results have been reported.

Modalities: RNA therapyCircular RNA therapy
Industry: Biotech

Beyond the preview

Go deeper on Laride.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laride.

Explore the full profile